Global EPA and DHA Market, By Type (Eicosapentaenoic Acid (EPA), and Docosahexaenoic Acid (DHA)), By Concentration Type (High Concentrated, Medium Concentrated, and Low Concentrated), By Form (Triglycerides, and Ethyl Esters). By Source (Fish Oil, Algae Oil, Krill Oil, and Other Sources), By Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI397320 | Publish Date: May 2023 | No. of Pages: 156

Global EPA And DHA Market Overview

Introduction:

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are chain omega-3 polyunsaturated fatty acids that are abundantly found in fatty layers of cold-water fish and shellfish, plant and nut oils, English walnuts, flaxseed, algae oils, and fortified foods. Food and supplement sources of these fatty acids differ in the forms and amounts they contain. This EPA and DHA are important to develop and function optimally in every stage of life. This help reduces inflammation and your risk of chronic diseases, such as heart disease. On its own, DHA supports brain function and eye health.

Drivers and Restraints:

Continuous demand due to the increasing popularity of EPA/DHA omega-3 as nutritional supplement products which drive the target market growth. The various health benefits provided by EPA and DHA product such as reduce inflammation and risk of chronic diseases, such as heart disease are the major factor drives target market growth. Therefore the rising prevalence of chlorine diseases fuels the market growth. For instance according to fightchronicdisease.org chronic diseases are accountable for seven out of every 10 deaths in the U.S., killing around 1.7 million Americans every year. Additionally, the growing standard of living, with rising health consciousness and rise in disposal income such factor are demanding for nutritious food which led to lifting the growth for the target market. Furthermore, R&D and strong marketing of EPA/DHA products are boosting the market growth. However, some side effects of EPA and DHA supplements are expected to hamper the market growth.

Segmentation:

The global EPA and DHA market is segmented based on by type, by concentration type, by form, by source, by application and region.

By type, the global EPA and DHA market is classified into eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). By concentration type the global EPA and DHA market is classified into high concentrated, medium concentrated, and low concentrated. Form the global EPA and DHA market is classified into Triglycerides and Ethyl Esters. By source, the global EPA and DHA market is classified into Fish Oil, Algae Oil, Krill Oil, and Other Sources. By application, the global EPA and DHA market is classified into Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Other Applications. Dietary supplements are accepted to dominate the market segment owing to rising consumption of such supplement with introducing new such as started consuming capsules for omega-3 and other. Which led to drive the segment growth.

By region, North America is expected to dominate the target market share. Owing to the rising prevalence of chlorine diseases in the region. Additionally, they demand EPA and DHA product due to rising awareness about the benefits of EPA and DHA supplement. Additionally, the high presence of the key player in the market such as Cargill, Nordic Naturals, and Algysis Are the major factor driving the growth for the target market in the region.

Key Players:   

The key players operating the global EPA and DHA market include Koninklijke DSM N.V, KD Pharma Group, Archer Daniels Midland Company, Corbion N.V., Novasep Holding SAS, Neptune Wellness Solutions, BASF SE and Clover Corporation Ltd.  The key players are focusing on partnership and mutual understanding strategy. For example on Jul. 2019 DSM, (a global science-based company in Nutrition, Health and Sustainable Living), and Evonik announced the opening of their Veramaris 50-50 joint venture's commercial-scale. This new site has arisen for the commercial production of omega-3 fatty acids rich in EPA and DHA from natural marine algae for sustainable salmon farming. 

Detailed Segmentation:

Global EPA and DHA Market, By Type:

  • Eicosapentaenoic Acid (EPA)
  •  Docosahexaenoic Acid (DHA)

 Global EPA and DHA Market, By Concentration Type:

  • High Concentrated
  • Medium Concentrated
  • Low Concentrated

Global EPA and DHA Market, By Form:

  • Triglyceride
  • Ethyl Esters

Global EPA and DHA Market, By Source:

  • Fish Oil
  • Algae Oil
  • Krill Oil
  • Other Sources

Global EPA and DHA Market, By Application:

  • Infant Formulae
  • Dietary Supplements
  • Fortified Food and Beverages
  • Pharmaceuticals
  • Other Applications

Global EPA and DHA Market, By Region:

      • North America
        • North America EPA and DHA  Market, By Type
        • North America EPA and DHA  Market, By Concentration Type
        • North America EPA and DHA  Market, By Form
        • North America EPA and DHA  Market, By Source
        • North America EPA and DHA  Market, By Application
        • North America EPA and DHA  Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe EPA and DHA  Market, By Type
        • Europe EPA and DHA  Market, By Concentration Type
        • Europe EPA and DHA  Market, By Form
        • Europe EPA and DHA  Market, By Source
        • Europe EPA and DHA  Market, By Application
        • Europe EPA and DHA  Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific EPA and DHA  Market, By Type
        • Asia Pacific EPA and DHA  Market, By Concentration Type
        • Asia Pacific EPA and DHA  Market, By Form
        • Asia Pacific EPA and DHA  Market, By Source
        • Asia Pacific EPA and DHA  Market, By Application
        • Asia Pacific EPA and DHA  Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
        • Latin America EPA and DHA  Market, By Type
        • Latin America EPA and DHA  Market, By Concentration Type
        • Latin America EPA and DHA  Market, By Form
        • Latin America EPA and DHA  Market, By Source
        • Latin America EPA and DHA  Market, By Application
        • Latin America EPA and DHA  Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa EPA and DHA  Market, By Type
        • Middle East & Africa EPA and DHA  Market, By Concentration Type
        • Middle East & Africa EPA and DHA  Market, By Form
        • Middle East & Africa EPA and DHA  Market, By Source
        • Middle East & Africa EPA and DHA  Market, By Application
        • Middle East & Africa EPA and DHA  Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Company Profile:

  • Koninklijke DSM N.V
        • Company Overview
        • By Concentration Type Portfolio
        • Key Highlights
        • Financial Performance
        • Business Strategies
  • KD Pharma Group
  • Archer Daniels Midland Company
  • Corbion N.V.
  •  Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Clover Corporation Ltd

 “*” marked represents similar segmentation in other categories in the respective section

Global EPA And DHA Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for EPA and DHA Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Concentration Type
      • Market Snippet, By Form
      • Market Snippet, By Source
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global EPA and DHA  Market, By Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Eicosapentaenoic Acid (EPA)
    • Docosahexaenoic Acid (DHA)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global EPA and DHA  Market, By By Concentration Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • High Concentrated
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Medium Concentrated
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Low Concentrated
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global EPA and DHA  Market, By Form, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Triglyceride
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Ethyl Esters
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global EPA and DHA  Market, By Source, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Fish Oil
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Algae Oil
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Krill Oil
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Sources
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global EPA and DHA  Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Infant Formulae
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Dietary Supplements
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Fortified Food and Beverages
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmaceuticals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Applications
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  10. Global EPA and DHA  Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Concentration Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Source, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Concentration Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Source, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Concentration Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Source, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Concentration Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Source, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Concentration Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Source, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  11. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  12. Company Profiles
  • Koninklijke DSM N.V
        • Company Overview
        • By Concentration Type Portfolio
        • Key Highlights
        • Financial Performance
        • Business Strategies
  • KD Pharma Group
  • Archer Daniels Midland Company
  • Corbion N.V.
  •  Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Clover Corporation Ltd
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The EPA and DHA market report is segmented into by type, by concentration type, by form, by source, by application and region.

Driving factors include the increasing awareness of omega-3 fatty acids' health benefits, the rising prevalence of chronic diseases, and the growing demand for dietary supplements.

Global restraints may involve concerns about overfishing, the impact of environmental changes on fish populations, and competition from plant-based sources of omega-3 fatty acids.

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is estimated to dominate the EPA and DHA Market, experiencing a significantly high revenue share over the forecast period.

The key players operating in the pharmaceutical and nutritional ingredients industry include KD Pharma Group, Archer Daniels Midland Company, Corbion N.V., Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, and Koninklijke DSM N.V.